1270B |
Clonazepam and Metabolite, Blood |
1270FL |
Clonazepam and Metabolite, Fluid |
1270SP |
Clonazepam and Metabolite, Serum/Plasma |
1270TI |
Clonazepam and Metabolite, Tissue |
1270U |
Clonazepam and Metabolite, Urine |
8088B |
Qsymia®, Blood |
8088SP |
Qsymia®, Serum/Plasma |
8897OF |
Drugs of Abuse (7 Panel) (Qualitative), Oral Fluid (Saliva) |
8898OF |
Drugs of Abuse (6 Panel) (Qualitative), Oral Fluid (Saliva) |
9139B |
Clonazepam and Metabolite Screen, Blood |
9139FL |
Clonazepam and Metabolite Screen, Fluid |
9139SP |
Clonazepam and Metabolite Screen, Serum/Plasma |
9139U |
Clonazepam and Metabolite Screen, Urine |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |